Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Torrance, CA
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Torrance, CA
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Upland, CA
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Upland, CA
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Jacksonville, FL
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Oviedo, FL
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Oviedo, FL
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Lexington, KY
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Shreveport, LA
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Brookline, MA
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Brookline, MA
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Renton, WA
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Renton, WA
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Kansas City, MO
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
LawrenceVille, NJ
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
LawrenceVille, NJ
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Albany, NY
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Albany, NY
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
New York, NY
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Rochester, NY
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Franklin, OH
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Franklin, OH
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Medford, OR
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Medford, OR
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Warwick, RI
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Warwick, RI
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Mount Pleasant, SC
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Nashville, TN
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
San Antonio, TX
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
West Valley City, UT
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
West Valley City, UT
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Richmond, VA
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Birmingham, AL
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Tucson, AZ
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Sugar Land, TX
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Norfolk, VA
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
A Multiple-dose, 52-week Study to Evaluate the Efficacy and Safety of Testosterone Enanthate Administered Subcutaneously Once Each Week to Adult Males With Hypogonadism
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Effect of a Medium Chain Triglyceride Supplemented Diet on Cognitive Function and Brain Activation in Type 1 Diabetes.
The Effect of a Long-term Medium Chain Supplemented Diet on Cognitive Function and Brain Activation During Hypoglycemia in Type 1 Diabetes.
Status: Enrolling
Updated:  1/12/2018
Yale University School of Medicine
mi
from
New Haven, CT
Effect of a Medium Chain Triglyceride Supplemented Diet on Cognitive Function and Brain Activation in Type 1 Diabetes.
The Effect of a Long-term Medium Chain Supplemented Diet on Cognitive Function and Brain Activation During Hypoglycemia in Type 1 Diabetes.
Status: Enrolling
Updated: 1/12/2018
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
The Effect of Artificial Sweeteners (AFS) on Sweetness Sensitivity, Preference and Brain Response in Adolescents
The Effect of Artificial Sweeteners (AFS) on Sweetness Sensitivity, Preference and Brain Response in Adolescents
Status: Enrolling
Updated:  1/12/2018
John B. Pierce Laboratory
mi
from
New Haven, CT
The Effect of Artificial Sweeteners (AFS) on Sweetness Sensitivity, Preference and Brain Response in Adolescents
The Effect of Artificial Sweeteners (AFS) on Sweetness Sensitivity, Preference and Brain Response in Adolescents
Status: Enrolling
Updated: 1/12/2018
John B. Pierce Laboratory
mi
from
New Haven, CT
Click here to add this to my saved trials
Dietary Intervention in Type-2 Diabetes and Pre-Diabetes
Dietary Intervention in Type-2 Diabetics and Pre-Diabetics Emphasizing Personalized Carbohydrate Intake
Status: Enrolling
Updated:  1/12/2018
IU Health Arnett Medical Weight Loss
mi
from
West Lafayette, IN
Dietary Intervention in Type-2 Diabetes and Pre-Diabetes
Dietary Intervention in Type-2 Diabetics and Pre-Diabetics Emphasizing Personalized Carbohydrate Intake
Status: Enrolling
Updated: 1/12/2018
IU Health Arnett Medical Weight Loss
mi
from
West Lafayette, IN
Click here to add this to my saved trials
Study to Investigate Benefits of Weight Loss in Young Adults and Adolescents
Study to Investigate Benefits of Weight Loss in Yound Adults and Adolescents
Status: Enrolling
Updated:  1/12/2018
Yale University
mi
from
New Haven, CT
Study to Investigate Benefits of Weight Loss in Young Adults and Adolescents
Study to Investigate Benefits of Weight Loss in Yound Adults and Adolescents
Status: Enrolling
Updated: 1/12/2018
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth
Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth
Status: Enrolling
Updated:  1/16/2018
47 College Street
mi
from
New Haven, CT
Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth
Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth
Status: Enrolling
Updated: 1/16/2018
47 College Street
mi
from
New Haven, CT
Click here to add this to my saved trials
The Impact of Free Fatty Acid Reduction on Vascular Function in the Metabolic Syndrome
The Impact of Free Fatty Acid Reduction on Vascular Function in the Metabolic Syndrome
Status: Enrolling
Updated:  1/16/2018
Brigham and Women's Hosp
mi
from
Boston, MA
The Impact of Free Fatty Acid Reduction on Vascular Function in the Metabolic Syndrome
The Impact of Free Fatty Acid Reduction on Vascular Function in the Metabolic Syndrome
Status: Enrolling
Updated: 1/16/2018
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Measurement of Glucose Metabolism in Humans Using Magnetic Resonance at 4 Tesla. Substudy: Hypoglycemia Unawareness
Measurement of Glucose Metabolism in Humans Using Magnetic Resonance at 4 Tesla. Substudy: Hypoglycemia Unawareness
Status: Enrolling
Updated:  1/16/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Measurement of Glucose Metabolism in Humans Using Magnetic Resonance at 4 Tesla. Substudy: Hypoglycemia Unawareness
Measurement of Glucose Metabolism in Humans Using Magnetic Resonance at 4 Tesla. Substudy: Hypoglycemia Unawareness
Status: Enrolling
Updated: 1/16/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Multi-Channel Automated Diet and Physical Activity Intervention for Pre-Diabetics
Multi-Channel Automated Diet and Physical Activity Intervention for Pre-Diabetics (ALIVE-PD)
Status: Enrolling
Updated:  1/16/2018
Palo Alto Medical Foundation Research Institute
mi
from
Palo Alto, CA
Multi-Channel Automated Diet and Physical Activity Intervention for Pre-Diabetics
Multi-Channel Automated Diet and Physical Activity Intervention for Pre-Diabetics (ALIVE-PD)
Status: Enrolling
Updated: 1/16/2018
Palo Alto Medical Foundation Research Institute
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Effect of Saxagliptin Treatment on Myocardial Fat Content, and Monocyte Inflammation
Effect of Saxagliptin Treatment on Myocardial Fat Content, Left Ventricular Function, and Monocyte Inflammation in Patients With Impaired Glucose Tolerance
Status: Enrolling
Updated:  1/16/2018
Baylor College of Medicine
mi
from
Houston, TX
Effect of Saxagliptin Treatment on Myocardial Fat Content, and Monocyte Inflammation
Effect of Saxagliptin Treatment on Myocardial Fat Content, Left Ventricular Function, and Monocyte Inflammation in Patients With Impaired Glucose Tolerance
Status: Enrolling
Updated: 1/16/2018
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
PK/PD STUDY OF U-500 REGULAR INSULIN
DURATION OF ACTION AND PEAK EFFECT OF HIGH DOSE OF U-500 REGULAR INSULIN IN SEVERELY INSULIN RESISTANT SUBJECTS WITH TYPE 2 DIABETES MELLITUS.
Status: Enrolling
Updated:  1/16/2018
Univ of Minnesota
mi
from
Minneapolis, MN
PK/PD STUDY OF U-500 REGULAR INSULIN
DURATION OF ACTION AND PEAK EFFECT OF HIGH DOSE OF U-500 REGULAR INSULIN IN SEVERELY INSULIN RESISTANT SUBJECTS WITH TYPE 2 DIABETES MELLITUS.
Status: Enrolling
Updated: 1/16/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Randomized Double Blinded Study to Examine the Use of N-acetyl Cysteine for the Prevention and Treatment of HAAF in Patients With Type 1 Diabetes
A Randomized Double Blinded Study to Examine the Use of N-Acetyl Cysteine for the Prevention and Treatment of HAAF in Patients With Type 1 Diabetes
Status: Enrolling
Updated:  1/16/2018
University of Minnesota Department of Medicine, Division of Diabetes, Endocrinology and Metabolism
mi
from
Minneapolis, MN
A Randomized Double Blinded Study to Examine the Use of N-acetyl Cysteine for the Prevention and Treatment of HAAF in Patients With Type 1 Diabetes
A Randomized Double Blinded Study to Examine the Use of N-Acetyl Cysteine for the Prevention and Treatment of HAAF in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 1/16/2018
University of Minnesota Department of Medicine, Division of Diabetes, Endocrinology and Metabolism
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated:  1/16/2018
Children´s Hospital Los Angeles
mi
from
Los Angeles, CA
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated: 1/16/2018
Children´s Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated:  1/16/2018
Stanford Univ Med Ctr
mi
from
Stanford, CA
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated: 1/16/2018
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated:  1/16/2018
1st Allergy and Clinical Research Center
mi
from
Englewood, CO
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated: 1/16/2018
1st Allergy and Clinical Research Center
mi
from
Englewood, CO
Click here to add this to my saved trials
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated:  1/16/2018
Allergy Associates of the Palm Beaches, PA
mi
from
North Palm Beach, FL
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated: 1/16/2018
Allergy Associates of the Palm Beaches, PA
mi
from
North Palm Beach, FL
Click here to add this to my saved trials
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated:  1/16/2018
University of South Florida; Asthma, Allergy & Immunology CRU
mi
from
Tampa, FL
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated: 1/16/2018
University of South Florida; Asthma, Allergy & Immunology CRU
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated:  1/16/2018
Rush-Presbyterian-St. Luke's Medical Center
mi
from
Chicago, IL
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated: 1/16/2018
Rush-Presbyterian-St. Luke's Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated:  1/16/2018
Children´s Hospital Boston
mi
from
Boston, MA
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated: 1/16/2018
Children´s Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated:  1/16/2018
Allergy, Asthma & Immunology Assoc.
mi
from
Omaha, NE
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated: 1/16/2018
Allergy, Asthma & Immunology Assoc.
mi
from
Omaha, NE
Click here to add this to my saved trials
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated:  1/16/2018
The Asthma & Allergy Center, P.C.
mi
from
Papillion, NE
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated: 1/16/2018
The Asthma & Allergy Center, P.C.
mi
from
Papillion, NE
Click here to add this to my saved trials
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated:  1/16/2018
Pediatric Allergy/Immunology Associates
mi
from
Dallas, TX
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated: 1/16/2018
Pediatric Allergy/Immunology Associates
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated:  1/16/2018
Montefiore Medical Center, Albert Einstein College of Medicine
mi
from
Bronx, NY
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated: 1/16/2018
Montefiore Medical Center, Albert Einstein College of Medicine
mi
from
Bronx, NY
Click here to add this to my saved trials
Impact of Chemokine Receptor 5 (CCR5) Inhibition on Sarcoidosis Immunophenotypes
An Interventional Study of the Effect of CCR5 Inhibition With Maraviroc on Immune Cells in the the Lung and in Peripheral Blood of Patients With Sarcoidosis
Status: Enrolling
Updated:  1/17/2018
Dorothy P. and Richard P. Simmons center for Interstitial lung Disease at the University of Pittsburgh
mi
from
Pittsburgh, PA
Impact of Chemokine Receptor 5 (CCR5) Inhibition on Sarcoidosis Immunophenotypes
An Interventional Study of the Effect of CCR5 Inhibition With Maraviroc on Immune Cells in the the Lung and in Peripheral Blood of Patients With Sarcoidosis
Status: Enrolling
Updated: 1/17/2018
Dorothy P. and Richard P. Simmons center for Interstitial lung Disease at the University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Assessment of Renin Inhibition on Insulin Sensitivity, Diastolic Function and Aortic Compliance
Assessment of Renin Inhibition on Insulin Sensitivity, Diastolic Function and Aortic Compliance
Status: Enrolling
Updated:  1/18/2018
Brigham and Women's Hosp
mi
from
Boston, MA
Assessment of Renin Inhibition on Insulin Sensitivity, Diastolic Function and Aortic Compliance
Assessment of Renin Inhibition on Insulin Sensitivity, Diastolic Function and Aortic Compliance
Status: Enrolling
Updated: 1/18/2018
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Bioequivalency Study of Calcitriol Tablets Under Fasting Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalency Study of Calcitriol Tablets, 0.25 mg, Under Fasting Conditions
Status: Enrolling
Updated:  1/19/2018
Bio-Kinetic Clinical Applications, Inc.
mi
from
Springfield, MO
Bioequivalency Study of Calcitriol Tablets Under Fasting Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalency Study of Calcitriol Tablets, 0.25 mg, Under Fasting Conditions
Status: Enrolling
Updated: 1/19/2018
Bio-Kinetic Clinical Applications, Inc.
mi
from
Springfield, MO
Click here to add this to my saved trials